Uric acid and transplantation

Seminars in Nephrology

Volumn 25, Issue 1, 2005, Pages 50-55

  Mazzali, Marilda ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMILORIDE; AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BENZBROMARONE; BENZIODARONE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; EVEROLIMUS; FENOFIBRATE; IRBESARTAN; LOOP DIURETIC AGENT; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SPIRONOLACTONE; STEROID; TACROLIMUS; TERTATOLOL; THIAZIDE DIURETIC AGENT; TRIAMTERENE; URIC ACID;

ACUTE GRAFT REJECTION; BLOOD PRESSURE REGULATION; BONE MARROW DEPRESSION; BONE MARROW TOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; GOUT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOW DRUG DOSE; METABOLIC DISORDER; METABOLISM; MYOPATHY; NEPHROTOXICITY; NONHUMAN; NUTRITIONAL HEALTH; PRIORITY JOURNAL; RECIPIENT; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SIDE EFFECT; TOXICITY;

EID: 12344324949     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.09.008     Document Type: Article

References (66)

1. D.M. Clive Renal transplant associated hyperuricemia and gout J Am Soc Nephrol 11 2000 974 979
2. K.J. Ahn, Y.S. Kim, H.C. Lee Cyclosporine induced hyperuricemia after renal transplant Clinical characteristics and mechanisms Transplant Proc 24 1992 1391 1392
3. H.Y. Lin, L.L. Rocher, M.A. McQuillan Cyclosporine induced hyperuricemia and gout N Engl J Med 321 1989 287 292
4. V. Delaney, N. Sumrani, P. Daskalakis Hyperuricemia and gout in renal transplant recipients Transplant Proc 24 1992 1773 1774
5. D.A.J. Neal, B.D.M. Tom, A.E.S. Gimson Hyperuricemia, gout and renal function after liver transplantation Transplantation 72 2001 1689 1691
6. J. Taillander, M. Allemanni, F. Liote Serum uric acid and liver transplantation Transplant Proc 27 1995 2189
7. D.A. Burack, B.P. Griffith, M.E. Thompson Hyperuricemia and gout among heart transplant recipients receiving cyclosporine Am J Med 92 1992 141 146
8. C. West, B.J. Carpenter, T.R. Hakala The incidence of gout in renal transplant recipients Am J Kidney Dis 10 1987 369 371
9. T.C. Noordzij, K.M. Leunissen, J.P. Van Hooff Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use Transplantation 52 1991 64 67
10. O.S. Better Tubular dysfunction following kidney transplantation Nephron 25 1980 209 213
11. R. Marcén, N. Gallego, L. Orofino Impairment of tubular secretion of urate in renal transplant patients on cyclosporine Nephron 70 1995 307
12. J.M. Hansen, N. Fogh Andersen Glomerular and tubular function in renal transplant patients treated with and without cyclosporin A Nephron 80 1998 450 457
13. P.F. Gores, D.S. Fryd, D.E.R. Sutherland Hyperuricemia after renal transplantation Am J Surg 156 1988 397 400
14. G.B. Ellion The pharmacology of azathioprine Ann N Y Acad Sci 685 1993 401 407
15. D. Cummings, M. Sekar, O. Halil Myelosuppression associated with azathioprine allopurinol interaction after heart and lung transplantation Transplantation 61 1996 1661 1662
16. R.G. Venkat, V.L. Sharman, H.Á Lee Azathioprine and allopurinol A potentially dangerous combination J Intern Med 228 1990 69 71
17. R.A. Navascues, E. Gomez, M. Rodriguez Safety of the allopurinol- mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients Nephron 91 2002 173 174
18. F. Jacobs, M. Manzer, F. Bruneel Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant patients with gout Transplantation 64 1997 1087 1088
19. W.M. Bennett, A. De Mattos, M.M. Meyer Chronic cyclosporine nephropathy. The Achilles' heel of immunosuppressive therapy Kidney Int 50 1996 1098
20. J. Laine, C. Holmberg Mechanisms of hyperuricemia in cyclosporine treated renal transplanted children Nephron 74 1996 318
21. R.M. Zurcher, H.A. Bock, G. Thiel Hyperuricemia in cyclosporine treated patients A GFR effect Nephrol Dial Transplant 11 1996 153
22. T. Ochiai, M. Ishibashi, K. Fukao Japanese multicenter studies of FK506 in renal transplantation Transplant Proc 27 1995 50 52
23. H.L. Pilmore, B. Faire, I. Dittmer Tacrolimus for treatment of gout in renal transplantation Transplantation 72 2001 1703 1705
24. The Sirolimus European Renal Transplant Study B. Charpentier Bicêtre Hospital Experience with sirolimus based therapy in human renal transplantation: The Sirolimus European Renal Transplant Study Transplant Proc 35 suppl A 2003 58S 61S
25. Sirolimus European Renal Transplant Study Group J.M. Morales, L. Wramner, H. Kreis Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients Am J Transplant 2 2002 436 442
26. M. Mazzali, J. Kanellis, L. Han Hyperuricemia induces a primary arteriolopathy in the rats by a blood pressure independent mechanism Am J Physiol 282 2002 F991
27. S. Aker, K. Ivens, B. Grabensee Cardiovascular risk factors and diseases after renal transplantation Int J Urol Nephrol 30 1998 777 788
28. E.M. Dimeny Cardiovascular disease after renal transplantation Kidney Int Suppl 80 2002 S78 S84
29. U. Gerhardt, M. Grobe Huttmann, H. Hohage Influence of hyperglycemia and hyperuricemia on long term transplant survival in kidney transplant patients Clin Transplant 13 1999 375 379
30. M. Mazzali, Y.G. Kim, S. Suga Hyperuricemia exacerbates chronic cyclosporine nephropathy Transplantation 71 2001 900 905
31. L.G. Sanchez-Lozada, E. Tapia, C. Avila-Casado Mild hyperuricemia induces glomerular hypertension in the rat Am J Physiol 283 2002 F1105 F1110
32. M. Sabbatini, L. De Nicola, G. Samsone Renal hypoperfusion as the primary cause of cyclosporine induced nephropathy Nephrol Dial Transplant 8 1993 794 797
33. M. Mazzali, J. Hughes, Y.G. Kim Elevated uric acid increases blood pressure in the rat by a novel crystal independent mechanism Hypertension 38 2001 1101 1106
34. R.H. Pichler, N. Franceschini, B.A. Young Pathogenesis of cyclosporine nephropathy Roles of angiotensin II and osteopontin J Am Soc Nephrol 6 1995 1186 1196
35. E.A. Burdmann, T.F. Andoh, C.C. Nast Prevention of experimental cyclosporine induced interstitial fibrosis by losartan and enalapril Am J Physiol 269 1995 F491 F499
36. B.A. Young, E.A. Burdmann, R.J. Johnson Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy Kidney Int 48 1995 431 438
37. A.O. Ojo, P.J. Held, F.K. Port Chronic renal failure after transplantation of a non renal organ N Engl J Med 349 2003 931 940
38. J.M. Moreno, V. Cuervas-Mons, E. Rubio Chronic renal dysfunction after liver transplantation in adult patients Prevalence, risk factors and impact on mortality Transplant Proc 35 2003 1907 1908
39. A. Oliveras, J. Roquer, J.M. Puig Stroke in renal transplant recipients Epidemiology, predictive risk factors and outcome Clin Transplant 17 2003 1 8
40. F. Perez-Ruiz, P. Gomez-Ullate, J.J. Amenabar Long term efficacy of hyperuricemia treatment in renal transplant patients Nephrol Dial Transplant 18 2003 603 606
41. R.J. Johnson, B.A. Rideout Uric acid and diet- insights into the epidemic of cardiovascular disease N Engl J Med 350 2004 1071 1073
42. the Rapamune Maintenance Regimen Trial H. Kreis, R. Oberbauer, J.P. Campistol Long term benefits with sirolimus based therapy after early cyclosporine withdrawal J Am Soc Nephrol 15 2004 809 817
43. T. Tedoriya, A.M. Keogh, K. Kusano Reversal of chronic cyclosporine nephrotoxicity after heart transplantation. Potential role of mycophenolate mofetil J Heart Lung Transplant 21 2002 976 982
44. M. Mazzali, K.R.S. Quadros, R.L.S. Santos Calcineurin inhibitor withdrawal in renal transplant recipients. Improvement in renal function and reduction of cardiovascular risk J Am Soc Nephrol 14 2003 650A (abstract)
45. C. Li, C.W. Yang, W.Y. Kim Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol 284 2003 F389 F398
46. M. Baryalei, D. Zenker, B. Pieske Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low dose cyclosporine Transplant Proc 35 2003 1539 1542
47. R.N. Saunders, G.R. Bicknell, M.L. Nicholson The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular and histological markers of chronic allograft nephropathy Transplantation 75 2003 772 780
48. S.M. Flechner, D. Goldfarb, C. Modlin Kidney transplantation without calcineurin inhibitor drugs A prospective, randomized trial of sirolimus versus cyclosporine Transplantation 74 2002 1070 1076
49. M. Burnier, F. Roch Ramel, H.R. Brunner Renal effects of angiotensin II receptor blockade in normotensive subjects Kidney Int 49 1996 1787
50. G. Minghelli, C. Seydoux, J.J. Goy Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients Transplantation 66 1998 268 271
51. A.L. Kamper, A.H. Nielsen Uricosuric effect of losartan in patients with renal transplants Transplantation 72 2001 671 674
52. A.J. Reyes Cardiovascular drugs and serum uric acid Cardiovasc Drug Ther 17 2003 397 414
53. A. Schmidt, U. Gruber, G. Bohmig The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CSA Nephrol Dial Transplant 16 2001 1034 1037
54. M. Nakashima, T. Uematsu, K. Kosuge Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist in healthy subjects Eur J Clin Pharmacol 42 1992 333 335
55. J. Chanard, O. Toupance, S. Lavaud Amlodipine reduces cyclosporine induced hyperuricemia in hypertensive renal transplant recipients Nephrol Dial Transplant 18 2003 2147 2153
56. R.M. Zurcher, H.A. Bock, G. Thiel Excellent uricosuric efficacy of benzbromarone in cyclosporine A treated renal transplant patients A prospective study Nephrol Dial Transplant 9 1994 548 551
57. P. Dupont, I. Hunt, L. Goldberg Colchicine myoneuropathy in a renal transplant patient Transplant Int 15 2002 374 376
58. D. Ducloux, V. Schuller, C. Bressson Vautrin Colchicine myopathy in renal transplant recipients on cyclosporine Nephrol Dial Transplant 12 1997 2389 2392
59. M. Elisaf Effects of fibrates on serum metabolic parameters Curr Med Res Opin 18 2002 269 276
60. S. Takahashi, Y. Moriwaki, T. Yamamoto Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism Ann Rheum Dis 62 2003 572 575
61. A.S. Wierzbicki, D.P. Mikhailidis, R. Wray Statin-fibrate combination therapy for hyperlipidemia a review Curr Med Res Opin 19 2003 155 168
62. J. Lipscombe, G.F. Lewis, D. Cattran Deterioration in renal function associated with fibrate therapy Clin Nephrol 55 2001 39 44
63. R.J. Johnson, S.D. Kivlighn, Y.G. Kim Reapprasial of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease and renal disease Am J Kidney Dis 33 1999 225 234
64. R.J. Johnson, D.H. Kang, D. Feig Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41 2003 1183 1190
65. T. Nakagawa, M. Mazzali, D.H. Kang Hyperuricemia causes glomerular hypertrophy in the rat Am J Nephrol 23 2003 2 7
66. R.J. Howard, P.R. Patton, A.I. Reed The changing causes of graft loss and death after kidney transplantation Transplantation 73 2002 1923 1928